{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:35:56Z","timestamp":1791045356187,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>IMA is a novel marker to consider in ischemic conditions. The initial stages of pregnancy represent a physiological ischemic status. IMA levels may be changed when there is suspicion of early pregnancy complications because of increased oxidative stress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>We aimed to determine and compare IMA values in cases of ectopic and healthy pregnancies as well as early pregnancy loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective case control study population (n = 91) consisted of early pregnancy loss (n = 28), ectopic pregnancy (n = 28), and an intracavitary early healthy pregnancy (n = 35). The serum IMA levels were compared in these groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Demographic parameters were similar and there was no significant difference between the three groups in terms of serum IMA concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We suggested that IMA cannot be used clinically for the diagnosis and follow up of early pregnancy complications during the first five to six gestational weeks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_1464_21","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T07:43:08Z","timestamp":1663746188000},"page":"975-978","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Ischemia-Modified Albumin (IMA) Levels in Ectopic Pregnancy and Early Pregnancy Loss"],"prefix":"10.4103","volume":"25","author":[{"given":"K","family":"Dogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Helvacioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Baghaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240907","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijcard.2010.01.013","article-title":"Assessment of ischemia-modified albumin concentrations for emergency room diagnosis of acute coronary syndrome","volume":"149","author":"Shen","year":"2011","journal-title":"Int J Cardiol"},{"key":"R2-1-20240907","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plefa.2018.07.014","article-title":"Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding","volume":"135","author":"Coverdale","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R3-1-20240907","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ajem.2007.11.023","article-title":"Ischemia-modified albumin concentrations in cerebrovascular accidents","volume":"26","author":"Gunduz","year":"2008","journal-title":"Am J Emerg Med"},{"key":"R4-1-20240907","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1309\/4BCTG5UCYMQFWBLR","article-title":"Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting","volume":"123","author":"Anwaruddin","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R5-1-20240907","first-page":"576","article-title":"Association between the plasma levels of IMA and coronary atherosclerotic plaque burden and ischemic burden in early phase of non-ST-segment-elevation acute coronary syndromes","volume":"21","author":"Turan","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R6-1-20240907","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/10641955.2015.1096371","article-title":"Ischemia-modified albumin (IMA): A novel marker for preeclampsia independent of uterine artery notching identified by doppler ultrasound","volume":"34","author":"Do\u011fan","year":"2015","journal-title":"Hypertens Pregnancy"},{"key":"R7-1-20240907","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0040-1709662","article-title":"The role of ischemia-modified albumin as a biomarker in preeclampsia","volume":"42","author":"Kara\u015fin","year":"2020","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R8-1-20240907","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/humrep\/dem095","article-title":"First trimester maternal serum ischaemia-modified albumin: A marker of hypoxia-ischaemia-driven early trophoblast development","volume":"22","author":"Prefumo","year":"2007","journal-title":"Hum Reprod"},{"key":"R9-1-20240907","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3109\/09513590.2012.683069","article-title":"Evaluation of serum ischemia-modified albumin levels in pregnant women with and without gestational diabetes mellitus","volume":"28","author":"Ma","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R10-1-20240907","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejogrb.2013.06.037","article-title":"Ischemia-modified albumin in pregnancy","volume":"170","author":"Rossi","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R11-1-20240907","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9440(10)63803-5","article-title":"Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies","volume":"162","author":"Jauniaux","year":"2003","journal-title":"Am J Pathol"},{"key":"R12-1-20240907","doi-asserted-by":"crossref","first-page":"l869","DOI":"10.1136\/bmj.l869","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: Prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"key":"R13-1-20240907","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.placenta.2004.05.011","article-title":"Pathophysiology of histological changes in early pregnancy loss","volume":"26","author":"Jauniaux","year":"2005","journal-title":"Placenta"},{"key":"R14-1-20240907","first-page":"1406","article-title":"Tubal ectopic pregnancy","volume":"2015","author":"Kumar","year":"2015","journal-title":"BMJ Clin Evid"},{"key":"R15-1-20240907","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/OGX.0b013e31829cdbeb","article-title":"Clinical diagnosis and treatment of ectopic pregnancy","volume":"68","author":"Alkatout","year":"2013","journal-title":"Obstet Gynecol Surv"},{"key":"R16-1-20240907","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/AOG.0b013e3182113c10","article-title":"Trends in ectopic pregnancy mortality in the United States: 1980-2007","volume":"117","author":"Creanga","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R17-1-20240907","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/00016340903568191","article-title":"The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy","volume":"89","author":"Horne","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R18-1-20240907","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/jfprhc-2011-0073","article-title":"Diagnosis and management of ectopic pregnancy","volume":"37","author":"Sivalingam","year":"2011","journal-title":"J Fam Plann Reprod Health Care"},{"key":"R19-1-20240907","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajog.2010.11.021","article-title":"Utility of dilation and curettage in the diagnosis of pregnancy of unknown location","volume":"204","author":"Shaunik","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R20-1-20240907","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/REP-09-0060","article-title":"Serum biomarkers of tubal ectopic pregnancy: Current candidates and future possibilities","volume":"138","author":"Cartwright","year":"2009","journal-title":"Reproduction"},{"key":"R21-1-20240907","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1093\/humrep\/dei218","article-title":"The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy","volume":"20","author":"Daponte","year":"2005","journal-title":"Hum Reprod"},{"key":"R22-1-20240907","first-page":"169","article-title":"Oxidative status and serum prolidase activity in tubal ectopic pregnancy","volume":"63","author":"Hilali","year":"2013","journal-title":"J Pak Med Assoc"},{"key":"R23-1-20240907","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1753495X16648495","article-title":"Oxidative stress in pregnancy and reproduction","volume":"9","author":"Duhig","year":"2016","journal-title":"Obstet Med"},{"key":"R24-1-20240907","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/14767058.2017.1422718","article-title":"Evaluation of maternal serum ischemia modified albumin and total antioxidant status in ectopic pregnancy","volume":"32","author":"Bozkaya","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R25-1-20240907","first-page":"1754","article-title":"Ischemia-modified albumin as an oxidative stress biomarker in early pregnancy loss","volume":"29","author":"Cengiz","year":"2016","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1464_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:14:36Z","timestamp":1787757276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1464_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_1464_21","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}